Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 US FDA ADVISORY COMMITTEE RECOMMENDS NO CARDIOVASCULAR OUTCOMES TRIAL FOR PERIPHERALLY-ACTING MU-OPIOID RECEPTOR ANTAGONIST (PAMORA) CLASS INCLUDING MOVANTIK Jun 12, 2014 Nektar Therapeutics Stock Trading Halted Today; FDA Advisory Committee to Discuss Peripherally-Acting Opioid Receptor Antagonists Jun 11, 2014 Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, at 50th ASCO Meeting Jun 01, 2014 Positive Data from Phase 2 Trial of NKTR-102 in Patients with Avastin®-Refractory High-Grade Glioma Presented at 50th ASCO Meeting May 31, 2014 Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer May 19, 2014 Nektar Therapeutics To Present at the UBS 2014 Global Healthcare Conference in New York City May 16, 2014 Nektar Therapeutics Reports Financial Results for the First Quarter of 2014 May 07, 2014 Nektar to Announce Financial Results for the First Quarter 2014 on Wednesday, May 7, 2014, After Close of U.S.-Based Financial Markets May 01, 2014 Nektar Reports Positive Preclinical Data for Two Oncology Programs at 2014 AACR Apr 09, 2014 Nektar Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results Feb 26, 2014 Pagination First page « first Previous page ‹ previous … Page 24 Page 25 Page 26 Page 27 Current page 28 Page 29 Page 30 Page 31 Page 32 … Next page next › Last page last »